Cargando…
Antituberculosis Macozinone Extended-Release Tablets To Enhance Bioavailability: a Pilot Pharmacokinetic Study in Beagle Dogs
Macozinone (MCZ; PBTZ169) is a first-in-class antituberculosis clinical-stage benzothiazinone-based drug candidate. Although its efficacy and safety have been strongly proven in several preclinical and clinical studies, the physicochemical and pharmacokinetic properties specific to MCZ required furt...
Autores principales: | Koryakova, Angela, Shcherbakova, Victoria, Riabova, Olga, Kazaishvili, Yurii, Bolgarin, Roman, Makarov, Vadim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927148/ https://www.ncbi.nlm.nih.gov/pubmed/36507624 http://dx.doi.org/10.1128/spectrum.02327-22 |
Ejemplares similares
-
Enhanced Bioavailability of Tadalafil after Intranasal Administration in Beagle Dogs
por: Kim, Jeong-Soo, et al.
Publicado: (2018) -
Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs
por: Gao, Yan-Yan, et al.
Publicado: (2022) -
Effect of Itraconazole on the Pharmacokinetics of Diclofenac in Beagle Dogs
por: Al-Jenoobi, Fahad I.
Publicado: (2010) -
Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles
por: Lai, Jie, et al.
Publicado: (2010) -
Pharmacokinetics of BMEDA after Intravenous Administration in Beagle Dogs
por: Chang, Chih-Hsien, et al.
Publicado: (2014)